Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review.

Rodríguez-Ruiz ME, San Miguel I, Gil-Bazo I, Perez-Gracia JL, Arbea L, Moreno-Jimenez M, Aristu J.

Radiat Oncol. 2012 Mar 28;7:50. doi: 10.1186/1748-717X-7-50. Review.

2.

Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.

Aoki M, Sato M, Hirose K, Akimoto H, Kawaguchi H, Hatayama Y, Ono S, Takai Y.

Radiat Oncol. 2015 Apr 22;10:99. doi: 10.1186/s13014-015-0406-8.

3.

Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors.

Kim SS, Song SY, Kwak J, Ahn SD, Kim JH, Lee JS, Kim WS, Kim SW, Choi EK.

Lung Cancer. 2013 Feb;79(2):161-6. doi: 10.1016/j.lungcan.2012.10.011. Epub 2012 Nov 20.

PMID:
23182662
4.

Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors.

Cunha MV, Al-Omair A, Atenafu EG, Masucci GL, Letourneau D, Korol R, Yu E, Howard P, Lochray F, da Costa LB, Fehlings MG, Sahgal A.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e343-9. doi: 10.1016/j.ijrobp.2012.04.034. Epub 2012 Jun 1.

PMID:
22658511
5.

Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.

Pettersson N, Nyman J, Johansson KA.

Radiother Oncol. 2009 Jun;91(3):360-8. doi: 10.1016/j.radonc.2009.03.022. Epub 2009 May 4.

PMID:
19410314
6.

Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy.

Taremi M, Hope A, Lindsay P, Dahele M, Fung S, Purdie TG, Jaffray D, Dawson L, Bezjak A.

Radiat Oncol. 2012 Sep 17;7:159. doi: 10.1186/1748-717X-7-159.

7.

Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship.

Asai K, Shioyama Y, Nakamura K, Sasaki T, Ohga S, Nonoshita T, Yoshitake T, Ohnishi K, Terashima K, Matsumoto K, Hirata H, Honda H.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):768-73. doi: 10.1016/j.ijrobp.2012.01.027. Epub 2012 Mar 23.

PMID:
22445398
8.

Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.

Thibault I, Al-Omair A, Masucci GL, Masson-Côté L, Lochray F, Korol R, Cheng L, Xu W, Yee A, Fehlings MG, Bjarnason GA, Sahgal A.

J Neurosurg Spine. 2014 Nov;21(5):711-8. doi: 10.3171/2014.7.SPINE13895. Epub 2014 Aug 29.

PMID:
25170656
9.

Pneumomediastinum as a complication of SABR for lung metastases.

Rodríguez-Ruiz ME, Arévalo E, Gil-Bazo I, Olarte García A, Valtueña G, Moreno-Jiménez M, Arbea-Moreno L, Aristu J.

Radiat Oncol. 2015 Jan 23;10:25. doi: 10.1186/s13014-015-0330-y.

10.

Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer.

Chen LM, Ignacio L, Jacobs R, Kozloff M, Telfer M, Elahi R, Evans R, Vijayakumar S.

Radiat Oncol Investig. 1999;7(1):49-53.

PMID:
10030624
11.

Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings?

Valentini V, Massaccesi M, Balducci M, Mantini G, Micciché F, Mattiucci GC, Dinapoli N, Meduri B, D'Agostino GR, Salvi G, Nardone L.

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):535-9. doi: 10.1016/j.ijrobp.2009.02.075. Epub 2009 Jun 18.

PMID:
19540061
12.

Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment--case report.

Hsieh CH, Chang HT, Lin SC, Chen YJ, Wang LY, Hsieh YP, Chen CA, Chong NS, Lin SL, Chen CY, Shueng PW.

BMC Cancer. 2010 Dec 31;10:696. doi: 10.1186/1471-2407-10-696.

13.

Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.

Dunlap NE, Cai J, Biedermann GB, Yang W, Benedict SH, Sheng K, Schefter TE, Kavanagh BD, Larner JM.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):796-801. doi: 10.1016/j.ijrobp.2009.02.027. Epub 2009 May 8.

PMID:
19427740
14.

Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.

Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE.

J Clin Oncol. 2009 Apr 1;27(10):1579-84. doi: 10.1200/JCO.2008.19.6386. Epub 2009 Mar 2.

15.

Lung metastases treated with image-guided stereotactic body radiation therapy.

Baschnagel AM, Mangona VS, Robertson JM, Welsh RJ, Kestin LL, Grills IS.

Clin Oncol (R Coll Radiol). 2013 Apr;25(4):236-41. doi: 10.1016/j.clon.2012.12.005. Epub 2013 Jan 24.

PMID:
23352916
16.

Late chest wall toxicity after MammoSite breast brachytherapy.

Brashears JH, Dragun AE, Jenrette JM.

Brachytherapy. 2009 Jan-Mar;8(1):19-25. doi: 10.1016/j.brachy.2008.07.007. Epub 2008 Oct 26.

PMID:
18955019
17.

Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors.

Nambu A, Onishi H, Aoki S, Tominaga L, Kuriyama K, Araya M, Saito R, Maehata Y, Komiyama T, Marino K, Koshiishi T, Sawada E, Araki T.

BMC Cancer. 2013 Feb 7;13:68. doi: 10.1186/1471-2407-13-68.

18.

Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases.

Boehling NS, Grosshans DR, Allen PK, McAleer MF, Burton AW, Azeem S, Rhines LD, Chang EL.

J Neurosurg Spine. 2012 Apr;16(4):379-86. doi: 10.3171/2011.11.SPINE116. Epub 2012 Jan 6.

PMID:
22225488
19.

Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors.

Diot Q, Kavanagh B, Schefter T, Gaspar L, Stuhr K, Miften M.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):1024-30. doi: 10.1016/j.ijrobp.2011.11.080. Epub 2012 May 12.

PMID:
22583607
20.

Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT).

Reyngold M, Wu AJ, McLane A, Zhang Z, Hsu M, Stein NF, Zhou Y, Ho AY, Rosenzweig KE, Yorke ED, Rimner A.

Radiat Oncol. 2013 Apr 25;8:99. doi: 10.1186/1748-717X-8-99.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk